James Geoghegan

Title: James Geoghegan: Innovator in Antibody Development

Introduction

James Geoghegan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on addressing critical health issues related to B-cell disorders.

Latest Patents

James Geoghegan holds a patent for "Anti-CD19 antibodies and uses thereof." This patent describes antibodies, fragments thereof, and fusion proteins that specifically bind to CD19. The methods of making and using such antibodies are also detailed in the patent. These innovations are particularly useful for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases. He has 1 patent to his name.

Career Highlights

Geoghegan's career is marked by his role at Millennium Pharmaceuticals Limited, where he has been instrumental in advancing research and development in antibody therapies. His expertise in the field has contributed to the company's reputation as a leader in biopharmaceutical innovation.

Collaborations

James has collaborated with talented professionals such as Daniel Tavares and Bianka Prinz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

James Geoghegan's contributions to antibody development represent a significant advancement in the treatment of B-cell disorders. His innovative work continues to impact the field of biotechnology positively.